S038 Dermatologic Surgery Pearls: Optimizing Safety, Satisfaction, Efficiency
DESCRIPTION
This session will recognize opportunities to enhance the overall dermatologic surgery practice by highlighting pearls to improve patient safety and satisfaction. Discussions will also focus on physician safety and tips on optimizing efficiency in the surgical setting.
LEARNING OBJECTIVES
Discuss pearls to optimize patient and physician safety while maximizing efficiency in the dermatologic surgery clinical practice.
Discuss strategies to improve patient experience and satisfaction.
SCHEDULE
1:00 PM
Managing postoperative pain
Frances M Walocko, MD, FAAD
1:16 PM
Optimizing patient satisfaction
Dana Lynn Sachs, MD, FAAD
1:32 PM
Photography/Biopsy site identification
Kishwer S. Nehal, MD, FAAD
1:50 PM
Questions & Answers
2:00 PM
Office design tips
Andrew R Shors, MD, MPH, FAAD
2:16 PM
Technology tools
David R. Carr, MD, FAAD
2:32 PM
Dermatologic surgery pearls
Valencia D. Thomas, MD, FAAD
2:50 PM
Questions & Answers
3:00 PM
Art of Preop Prep
Emily Clara Newsom, MD, FAAD
3:16 PM
Reducing risk of surgical injuries
Rachel Rigo, MD, FAAD
3:32 PM
Ergonomics in your practice
Patrick K. Lee, MD, FAAD
3:50 PM
Questions & Answers
DIRECTOR
Kishwer S. Nehal, MD, FAAD
SPEAKERS
David R. Carr, MD, FAAD
Patrick K. Lee, MD, FAAD
Emily Clara Newsom, MD, FAAD
Rachel Rigo, MD, FAAD
Dana Lynn Sachs, MD, FAAD
Andrew R Shors, MD, MPH, FAAD
Valencia D. Thomas, MD, FAAD
Frances M Walocko, MD, FAAD
DISCLOSURES
David R. Carr, MD, FAAD
Regeneron – Investigator(No Compensation Received);
Patrick K. Lee, MD, FAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.
Emily Clara Newsom, MD, FAAD
No financial relationships exist with ineligible companies.
Rachel Rigo, MD, FAAD
No financial relationships exist with ineligible companies.
Dana Lynn Sachs, MD, FAAD
No financial relationships exist with ineligible companies.
Andrew R Shors, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Valencia D. Thomas, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria); Merk – Advisory Board(Honoraria); National Comprehensive Cancer Network – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Frances M Walocko, MD, FAAD
No financial relationships exist with ineligible companies.